CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-18 | Kaye Edward M. MD Director | Sale | −11,930 | $32.01 | $382K | 125,194 |
| 2026-08-18 | Kaye Edward M. MD Director | Sale | −637 | $32.47 | $21K | 124,557 |
| 2026-08-14 | Kaye Edward M. MD Director | Exercise or conversion | +26,250 | 137,124 | ||
| 2026-08-14 | Kaye Edward M. MD Director | Exercise or conversion · Performance Stock Units | −26,250 | 0 | ||
| 2026-06-03 | Kaye Edward M. MD Director | Grant or award · Director Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Exercise or conversion | +35,500 | 84,624 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Exercise or conversion | +26,250 | 110,874 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Exercise or conversion · Restricted Stock Units | −35,500 | 35,500 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Exercise or conversion · Restricted Stock Units | −26,250 | 52,500 | ||
| 2025-12-08 | Kaye Edward M. MD Director | Sale 10b5-1 | −3,825 | $31.44 | $120K | 58,729 |
| 2025-12-08 | Kaye Edward M. MD Director | Sale 10b5-1 | −8,274 | $32.52 | $269K | 50,455 |
| 2025-12-08 | Kaye Edward M. MD Director | Sale 10b5-1 | −1,331 | $33.10 | $44K | 49,124 |
| 2025-12-05 | Kaye Edward M. MD Director | Sale 10b5-1 | −6,367 | $31.33 | $199K | 64,735 |
| 2025-12-05 | Kaye Edward M. MD Director | Sale 10b5-1 | −1,681 | $31.15 | $52K | 63,054 |
| 2025-12-05 | Kaye Edward M. MD Director | Sale 10b5-1 | −500 | $31.85 | $16K | 62,554 |
| 2025-12-04 | Kaye Edward M. MD Director | Sale 10b5-1 | −5,222 | $30.76 | $161K | 72,333 |
| 2025-12-04 | Kaye Edward M. MD Director | Sale 10b5-1 | −1,231 | $31.32 | $39K | 71,102 |
| 2025-12-03 | Kaye Edward M. MD Director | Exercise or conversion 10b5-1 | +26,250 | 77,555 | ||
| 2025-12-03 | Kaye Edward M. MD Director | Exercise or conversion · Performance Stock Units 10b5-1 | −26,250 | 0 | ||
| 2025-12-03 | Kaye Edward M. MD Director | Sale | −419 | $30.34 | $13K | 51,956 |
Page 1 of 4 · 75 trades